Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.44 |
| ▸ | NPC1 | O15118 | 5/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.44 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.44 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.44 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL973482 | 0.83 | ALDH1A1 (0.71) | ALDH1A1HSD17B10EPHX1NPC1SMN1; SMN2 | |
| Bicarbonate SCHEMBL11429542 | 0.83 | ALDH1A1 (0.71) | ALDH1A1HSD17B10EPHX1NPC1SMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL3862637 | 0.83 | PDK1 (0.42) | ALDH1A1EPHX1NPC1SMN1; SMN2RAB9A | |
| Trifluoroacetic Acid SCHEMBL4114059 | 0.80 | PDK1 (0.39) | ALDH1A1EPHX1NPC1SMN1; SMN2RAB9A | |
| Trifluoroacetic Acid SCHEMBL27702554 | 0.80 | PDK1 (0.43) | ALDH1A1EPHX1NPC1SMN1; SMN2RAB9A | |
| Trifluoroacetic Acid SCHEMBL16050159 | 0.80 | PDK1 (0.39) | ALDH1A1EPHX1NPC1SMN1; SMN2RAB9A | |
| Trifluoroacetic Acid SCHEMBL28005455 | 0.79 | PDK1 (0.43) | ALDH1A1EPHX1NPC1SMN1; SMN2RAB9A | |
| Trifluoroacetic Acid SCHEMBL2694612 | 0.78 | KDM1A (0.38) | — | |
| Acetic Acid SCHEMBL17714091 | 0.78 | ALDH1A1 (0.63) | ALDH1A1HSD17B10EPHX1NPC1SMN1; SMN2 | |
| Carbamic Acid SCHEMBL6932729 | 0.78 | ALDH1A1 (0.63) | ALDH1A1HSD17B10EPHX1NPC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114805289-B | Preparation method of 1, 4-oxathia-3, 5-dialdehyde cyclohexadiene compound | 昆明理工大学 | 2024-05-28 | — | — | CN | claimed |
| CN-114805289-A | Preparation method of 1, 4-oxathia-3, 5-dialdehyde cyclohexadiene compound | 昆明理工大学 | 2022-07-29 | — | — | CN | claimed |
| CN-114805289-B | Preparation method of 1, 4-oxathia-3, 5-dialdehyde cyclohexadiene compound | 昆明理工大学 | 2024-05-28 | — | — | CN | disclosed |
| CN-114805289-A | Preparation method of 1, 4-oxathia-3, 5-dialdehyde cyclohexadiene compound | 昆明理工大学 | 2022-07-29 | — | — | CN | disclosed |
| US-20120083526-A1 | SYNTHESIS OF 1-(2,3-DIHYDROBENZOFURAN-4-YL)ETHANONE AS INTERMEDIATE IN THE PREPARATION OF RAMELTEON | LEK PHARMACEUTICALS D.D. (SI) | 2012-04-05 | — | — | US | disclosed |
| US-20120071673-A1 | SYNTHESIS OF (S)-N-[2-(1,6,7,8-TETRAHYDRO-2H-INDENO-[5,4-B]FURAN-8-YL)ETHYL]PROPIONAMIDE | LEK PHARMACEUTICALS D.D. (SI) | 2012-03-22 | — | — | US | disclosed |
| EP-2417117-A2 | SYNTHESIS OF 1-(2,3-DIHYDROBENZOFURAN-4-YL)ETHANONE AS INTERMEDIATE IN THE PREPARATION OF RAMELTEON | LEK Pharmaceuticals d.d. (SI) | 2012-02-15 | — | — | EP | disclosed |
| EP-2396309-A1 | SYNTHESIS OF (S)-N-Ý2-(1,6,7,8-TETRAHYDRO-2H-INDENO-Ý5,4-B¨FURAN-8-YL)ETHYL¨PROPIONAMIDE | LEK Pharmaceuticals d.d. (SI) | 2011-12-21 | — | — | EP | disclosed |
| US-20110184058-A1 | SYNTHESIS OF 6,7-DIHYDRO-1H-INDENO[5, 4-B] FURAN-8(2H)-ONE AS INTERMEDIATE IN THE PREPARATION OF REMELTEON | LEK PHARMACEUTICALS D.D. (SI) | 2011-07-28 | — | — | US | disclosed |
| CN-102099348-A | Synthesis of 6, 7-dihydro-1H-indolo [5,4-B ] furan-8 (2H) -one as an intermediate for the preparation of lamisterone | LEK PHARMACEUTICALS | 2011-06-15 | — | — | CN | disclosed |
| EP-2328882-A1 | SYNTHESIS OF 6,7-DIHYDRO-1H-INDENO[5,4-B]FURAN-8(2H)-ONE AS INTERMEDIATE IN THE PREPARATION OF RAMELTEON | LEK Pharmaceuticals d.d. (SI) | 2011-06-08 | — | — | EP | disclosed |
| EP-2243775-A1 | Synthesis of 1-(2,3-Dihydrobenzofuran-4-YL)ethanone as intermediate in the preparation of ramelteon | LEK Pharmaceuticals d.d. (SI) | 2010-10-27 | — | — | EP | disclosed |
| WO-2010115897-A2 | SYNTHESIS OF 1-(2,3-DIHYDROBENZOFURAN-4-YL)ETHANONE AS INTERMEDIATE IN THE PREPARATION OF RAMELTEON | LEK PHARMACEUTICALS D.D. (SI) | 2010-10-14 | — | — | WO | disclosed |
| WO-2010092107-A1 | SYNTHESIS OF (S)-N-[2-(1,6,7,8-TETRAHYDRO-2H-INDENO-[5,4-B]FURAN-8-YL)ETHYL]PROPIONAMIDE | LEK PHARMACEUTICALS D.D. (SI) | 2010-08-19 | — | — | WO | disclosed |
| WO-2010007022-A1 | SYNTHESIS OF 6,7-DIHYDRO-1H-INDENO[5,4-B]FURAN-8(2H)-ONE AS INTERMEDIATE IN THE PREPARATION OF RAMELTEON | LEK PHARMACEUTICALS D.D. (SI) | 2010-01-21 | — | — | WO | disclosed |
| US-20090221811-A1 | PROCESS FOR PREPARING GEMCITABINE AND ASSOCIATED INTERMEDIATES | CHEMAGIS LTD. (IL) | 2009-09-03 | — | — | US | disclosed |
| WO-2007092705-A2 | PROCESS FOR PREPARING GEMCITABINE AND ASSOCIATED INTERMEDIATES | CHEMAGIS LTD. (IL) | 2007-08-16 | — | — | WO | disclosed |
| US-20070191598-A1 | Process for Preparing Gemcitabine and Associated Intermediates | CHEMAGIS LTD. (IL) | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120083526-A1 | SYNTHESIS OF 1-(2,3-DIHYDROBENZOFURAN-4-YL)ETHANONE AS INTERMEDIATE IN THE PREPARATION OF RAMELTEON | CYP2J2, CYP2E1, CYP2B6 | ALDH1A1 116/4885HSD17B10 624/4885EPHX1 553/4885 |
| US-20110184058-A1 | SYNTHESIS OF 6,7-DIHYDRO-1H-INDENO[5, 4-B] FURAN-8(2H)-ONE AS INTERMEDIATE IN THE PREPARATION OF REMELTEON | CYP2B6, CYP2D6, CYP2J2 | ALDH1A1 219/4885HSD17B10 378/4885EPHX1 495/4885 |
| US-20120071673-A1 | SYNTHESIS OF (S)-N-[2-(1,6,7,8-TETRAHYDRO-2H-INDENO-[5,4-B]FURAN-8-YL)ETHYL]PROPIONAMIDE | CYP2B6, CYP2D6, CYP2A6 | ALDH1A1 779/4885HSD17B10 2704/4885EPHX1 848/4885 |
| US-20070191598-A1 | Process for Preparing Gemcitabine and Associated Intermediates | DCTD, DPYD, THPO | ALDH1A1 718/4885HSD17B10 3827/4885EPHX1 97/4885 |
| US-20090221811-A1 | PROCESS FOR PREPARING GEMCITABINE AND ASSOCIATED INTERMEDIATES | THPO, DPYD, DCTD | ALDH1A1 722/4885HSD17B10 3425/4885EPHX1 71/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.